Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Ferrara

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Glia|December 31, 2020
Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytesTiziana Vigo, Androniki Voulgari-Kokota, Mariella Errede, et al.
Journal of Neuropathology and Experimental Neurology|September 25, 2012
Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitisMariella Errede, Francesco Girolamo, Giovanni Ferrara, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2005
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infectionGiovanni Ferrara, Monica Losi, Marisa Meacci, et al.
Acta Neuropathologica|March 31, 2016
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activationGiovanni Ferrara, Mariella Errede, Francesco Girolamo, et al.
Eclinicalmedicine|October 13, 2025
Exploring the temporal relationship between stigma, disease manifestations, and health outcomes in post COVID-19 condition: a longitudinal descriptive studyRonald W Damant, Liam Rourke, Grace Y Lam, et al.
Respiratory Research|August 7, 2021
Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype?Grace Y Lam, A Dean Befus, Ronald W Damant, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Skin disorders and interstitial lung disease: Part II-The spectrum of cutaneous diseases with lung disease associationLydia Ouchene, Anastasiya Muntyanu, Deborah Assayag, et al.
Journal of Neuroinflammation|August 2, 2020
Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migrationGiovanni Ferrara, Andrea Benzi, Laura Sturla, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 20, 2009
Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerabilityGiuseppe Lauria, Angela Campanella, Graziella Filippini, et al.
Frontiers in Physiology|July 25, 2022
Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controlsRhys I Beaudry, Andrew R Brotto, Rhea A Varughese, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Glia|December 31, 2020
Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytesTiziana Vigo, Androniki Voulgari-Kokota, Mariella Errede, et al.
Journal of Neuropathology and Experimental Neurology|September 25, 2012
Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitisMariella Errede, Francesco Girolamo, Giovanni Ferrara, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2005
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infectionGiovanni Ferrara, Monica Losi, Marisa Meacci, et al.
Acta Neuropathologica|March 31, 2016
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activationGiovanni Ferrara, Mariella Errede, Francesco Girolamo, et al.
Eclinicalmedicine|October 13, 2025
Exploring the temporal relationship between stigma, disease manifestations, and health outcomes in post COVID-19 condition: a longitudinal descriptive studyRonald W Damant, Liam Rourke, Grace Y Lam, et al.
Respiratory Research|August 7, 2021
Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype?Grace Y Lam, A Dean Befus, Ronald W Damant, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Skin disorders and interstitial lung disease: Part II-The spectrum of cutaneous diseases with lung disease associationLydia Ouchene, Anastasiya Muntyanu, Deborah Assayag, et al.
Journal of Neuroinflammation|August 2, 2020
Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migrationGiovanni Ferrara, Andrea Benzi, Laura Sturla, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 20, 2009
Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerabilityGiuseppe Lauria, Angela Campanella, Graziella Filippini, et al.
Frontiers in Physiology|July 25, 2022
Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controlsRhys I Beaudry, Andrew R Brotto, Rhea A Varughese, et al.
Pageof 11